mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0065 |
0.8 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.8 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.9 |